Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?

CONCLUSIONS: Our retrospective results suggest that HHIs should be continued after cCR to improve DFS in BCC.PMID:38127280 | DOI:10.1093/oncolo/oyad319

Source: The Oncologist - December 21, 2023 Category: Cancer & Oncology Authors: Salvatore Alfieri Rebecca Roman ò Sara Marceglia Vincenzo De Giorgi Ketty Peris Pietro Sollena Alfredo Piccerillo Ruggero Moro Giulio Gualdi Paolo Antonio Ascierto Marco Palla Miriam Paone Laura Eibenschutz Francesco Spagnolo Paola Queirolo Daria Maria F Source Type: research